#ACRBest
The late breaking abstracts are nearly here!

And my most anticipated one: TARA

Remember TLL-018, the Chinese JAK1/Tyk2 at #EULAR2023, smashing tofa in RA?

We said: come back with your ph3 data
They did. Same results

ABSTLB21 #ACR26 #ACRBest RheumNow (on X)
November 11, 2026 at 12:50 PM
TAPIR study of continuing vs stopping steroids in ANCA vasculitis in remission. Relapse at month 6 in 16% vs 4%. OR 4.22, but low rate in either group. If treated Rituximab, no difference! Merkel et al. @RheumNow #ACR24 Abstr#0774 #ACRbest
A Multicenter, Randomized, Controlled Trial to Evaluate the Effects of Low-dose Glucocorticoids Compared to Stopping Glucocorticoids to Maintain Remission of Granulomatosis with Polyangiitis: The TAPIR Trial - ACR Meeting Abstracts
Background/Purpose: Use of low-dose glucocorticoids to maintain remission in patients with granulomatosis with polyangiitis (GPA) remains controversial.  Additionally, there is no consensus on how to…
buff.ly
December 27, 2024 at 8:00 PM